Singapore, March 4 -- A University of Melbourne industry collaboration has been awarded $2.1 million by the Australian Government to build a quantum-enabled platform to support faster discovery and development of therapies for neurological diseases, including Alzheimer's.

The University has formed a consortium with technology companiesChromos Labs,Tessara Therapeutics,Quantum BrillianceandAxol Biosciencesto develop a quantum-enabled platform that measures real-time electrical activity from 3D human neural micro-tissues (known as brain-on-chip technology).

The 'quantum-enabled platform for neurological drug development' is one of eight quantum technology projects awarded a total of $12.7 million from Stage Two of the Critical Technologie...